Diabetic hepatosclerosis: A novel entity or a rare form of nonalcoholic fatty liver disease?

Hepatology

Volumn 44, Issue 5, 2006, Pages 1362-1363

  Mendoza, Michael ^a   Younossi, Zobair ^a  

^a INOVA FAIRFAX HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; EOSIN; HEMATOXYLIN;

BASEMENT MEMBRANE; CLINICAL ARTICLE; DIABETES HEPATOSCLEROSIS; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LIVER BIOPSY; LIVER FIBROSIS; MEDICAL RECORD; MICROANGIOPATHY; MICROSCOPY; NONALCOHOLIC FATTY LIVER; NOTE; PRIORITY JOURNAL;

EID: 33750981548     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.21349     Document Type: Note

References (11)

1. Shinohara M, Thornalley PJ, Giardino I, Beisswenger P, Thorpe SR, Onorato J, Brownlee M. Overexpression of glyozalase-1 in bovine endothelial cells inhibits intracellular advanced glycation end product formation and prevents hyperglycemia-induced increases in macromolecular endocytosis. J Clin Invest 1998;101:1142-1147.
2. Morita K, Urabe K, Moroi Y, Koga T, Nagai R, Horiuchi S, Furue M. Migration of keratinocytes is impaired on glycated collagen I. Wound Repair Regen 2005;13:93-101.
3. Schalkwijk CG, Lieuw-a-Fa M, van Hinsbergh VW, Stehouwer CD. Pathophysiological role of Amadori-glycated proteins in diabetic microangiopathy. Semin Vasc Med 2002;2:191-197.
4. Stokic E, Deric M, Radak D. [Endothelial dysfunction and diabetes] Med Pregl 2005;58(9-10):459-464.
5. Koka V, Wang W, Huang XR, Kim-Mitsuyama S, Truong LD, Lan HY. Advanced glycation end products activate a chymase-dependent angiotensin II-generating pathway in diabetic complications. Circulation 2006 14;113:1353-1360.
6. Renard C, Van Obberghen E. Role of diabetes in atherosclerotic pathogenesis. What have we learned from animal models? Diabetes Metab 2006;32:15-29.
7. Hudson BI, Wendt T, Bucciarelli LG, Rong LL, Naka Y, Yan SF, Schmidt AM. Diabetic vascular disease: it's all the RAGE. Antioxid Redox Signal 2005;7:1588-1600.
8. National Diabetes Fact Sheet, 2005. www.diabetes.org/uedocuments/ NationalDiabetesFactSheetRev.pdf.
9. Latry P, Bioulac-Sage P, Echinard E, Gin H, Boussarie L, Grimaud JA, Balabaud C. Perisinusoidal fibrosis and basement membrane-like material in the livers of diabetic patients. Hum Pathol 1987;18:775-780.
10. Ong JP, Younossi ZM. Approach to the diagnosis and treatment of non-alcoholic fatty liver disease. Clin Liver Dis 2005;9:617-634.
11. Cotrim HP, De Freitas LAR, Freitas C, Braga L, Sousa R, Carvalho F, et al. Clinical and histopatholigical features of NASH in workers exposed to chemicals with or without associated metabolic conditions. Liver Int 2004;24:131-135.